Incorporation into Endogenous Metabolic Pathways of Small Fragments Derived from I.C.I. 58,834 (Viloxazine)
- 1 January 1975
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 5 (3) , 133-143
- https://doi.org/10.3109/00498257509056099
Abstract
1. Metabolic degradation of the tetrahydro-oxazine ring of 2-(2-ethoxyphenoxymethyl)-2,3,5,6-tetrahydro-1,4-oxazine (I.C.I. 58,834) gives rise to one- or two-carbon fragments which are utilized by endogenous metabolic pathways. 2. Evidence of this in dogs is shown by the 14C-labelled residues in tissues, 14C-labelled material in blood which has a half-life of three weeks, and elimination of [14C]urea in urine. 3. The same phenomenon occurs in rat, mouse and man, but to a smaller extent than in the dog. 4. Intravenous administration of [14C]ethanolamine to a dog gave rise to residual 14C blood levels with a half-life comparable to that produced by metabolic incorporation of 14C from 14C-I.C.I. 58,834.Keywords
This publication has 9 references indexed in Scilit:
- The Disposition and Metabolism of LCI. 58,834 (ViloxazJne) in AnimalsXenobiotica, 1975
- The Disposition and Metabolism of I.C.I. 58,834 (Viloxazine) in HumansXenobiotica, 1975
- Carbon-14 balance and residues of dichlorvos and its metabolities in pigs dosed with carbon-14-labeled dichlorvosJournal of Agricultural and Food Chemistry, 1973
- Identification of Doxapram Metabolites using High Pressure Ion Exchange Chromatography and Mass SpectroscopyXenobiotica, 1973
- Metabolism and some biochemical effects of N-nitrosomorpholineBiochemical Journal, 1972
- The non‐metabolite residue a limitation to the tracer methodJournal of Labelled Compounds and Radiopharmaceuticals, 1971
- Metabolism of Propranolol (‘Inderal’), a Potent, Specific β-Adrenergic Receptor Blocking AgentNature, 1967
- Excretion, Distribution, and Metabolism of Doxapram HydrochlorideJournal of Medicinal Chemistry, 1965
- Messung der Neubildungs- und Abbaugeschwindigkeit einzelner Serumeiweißfraktionen nach Gabe von S35-MethioninVerhandlungen der Deutschen Gesellschaft für innere Medizin, 1953